![imrs.php](https://www.washingtonpost.com/wp-apps/imrs.php?src=https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/OSGGVIGTNMI6VDCVMHT7UXUCVM.jpg&w=916)
https://www.washingtonpost.com/nati...286b1a-d36a-11ea-8c55-61e7fa5e82ab_story.html
At first glance, the shipping trailers that arrived at the Italian port of Salerno appeared to contain only paper, rolled up on giant industrial spools as tall as a man. But when an investigator sliced into one of the rolls with an electric saw, he unleashed an avalanche of little beige pills.
Police found more caches inside other paper rolls, and by the time the search ended on July 1, customs agents had recovered 84 million tablets of the amphetamine Captagon. It was a record haul, worth an estimated $1.1 billion, and even more jarring was the suspect initially named by police as the likely source: the Islamic State.
Yet, within days, suspicions began to shift toward different Middle Eastern groups. Intelligence officials concluded that the drugs did originate in Syria, but in factories located in areas controlled by President Bashar al-Assad’s government. The amphetamines departed Syria from Latakia, a coastal city with dedicated Iranian port facilities, and a known hub for smuggling operations by Tehran’s ally, Hezbollah.
Italian police learned of the shipment because they happened to be monitoring the communications of a local crime family that was supposed to pick up the drugs, the authorities in Italy said.
Whether Hezbollah was directly involved in the Italian shipment is not yet known, but investigators say the episode fits a pattern of recent drug cases in the Middle East and Europe linked to the powerful Lebanese militia. Facing extreme financial pressures because of U.S. sanctions, the coronavirus pandemic and Lebanon’s economic collapse, Hezbollah appears to be growing increasingly reliant on criminal enterprises, including drug smuggling, to finance its operations, U.S. and Middle Eastern analysts said.
Law enforcement officials have linked Hezbollah to a string of major drug seizures, in locations ranging from the empty desert along the Syria-Jordan border to urban centers in Saudi Arabia and the United Arab Emirates, to central and southern Europe. Many of the cases involve counterfeit Captagon, a synthetic drug that Hezbollah operatives began manufacturing more than a decade ago and has gained prominence as a moneymaker as the group’s military and financial commitments have expanded, intelligence analysts say.
U.S. sanctions are hitting Hezbollah, and the pain is showing
“They have stepped up the whole business with Captagon. There is no doubt about that,” said a Middle Eastern intelligence official who closely tracks Hezbollah’s illicit enterprises. The analyst, like several other officials interviewed, requested anonymity to discuss sensitive intelligence assessments. “The thing is to find any way to bring money into the organization,” the official said, “and Captagon is additional income.”